Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: solid (48), dense (12), thick (51)

Capecitabine-Carboplatin(AUC5)-Cetuximab

Description: Chemotherapy Protocol HEAD AND NECK CANCER CAPECITABINE-CARBOPLATIN (AUC5)-CETUXIMAB Reg
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Capecitabine-Carboplatin-Cetuximab.pdf

Diarrhoea - patient information

Description: Patient information factsheet Diarrhoea Diarrhoea is passing looser or more frequent stools than is normal for you. It
Url: /Media/UHS-website-2019/Patientinformation/Generalmedicine/Diarrhoea-1360-PIL.pdf

Urinary tract infection - patient information

Description: Patient information factsheet Urinary tract infections (UTIs) Urinary tract infections (UTIs) are very common. They ca
Url: /Media/UHS-website-2019/Patientinformation/Generalmedicine/Urinary-tract-infection-1359-PIL.pdf

Carboplatin-Vinorelbine Oral

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC6)-VINORELBINE (Oral) Regimen  NSCLC
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-Oral.pdf

Guide to the Mental Capacity Act - patient information

Description: This leaflet provides an overview of the Mental Capacity Act 2005.
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Guide-to-the-Mental-Capacity-Act-2865-PIL.pdf

Anorectal physiology test - patient information

Description: We hope this factsheet will help to answer some of your questions about having an anorectal physiology test.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Anorectal-physiology-test-1554-PIL.pdf

Azacitidine Oral

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA -AZACITADINE (ORAL) Regimen • AML – AZACITADINE (ORAL) Indication Oral azacitidine a
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine-Oral.pdf

Audit and Risk Committee ToR Jan 2023

Description: Audit and Risk Committee Terms of Reference Version: 5 Date Issued: Review Date: Document Type: 31 January 2023 January 2024 Commi
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/Audit-and-Risk-Committee-ToR-Jan-2023.pdf

Neratinib

Description: Chemotherapy Protocol Breast Cancer NERATINIB Regimen • Breast Cancer – Neratinib Indication • Neratinib for extended adjuvant therapy for h
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Neratinib.pdf

Governors' Nomination Committee Terms of Reference Dec 2022

Description: Governors’ Nomination Committee Terms of Reference Date Issued: Review Date: Document Type: 17 January 2023 January 2024 Committee
Url: /Media/UHS-website-2019/Docs/Council-of-Governors/Governors-Nomination-Committee-Terms-of-Reference-Dec-2022.pdf

371 to 380 of 533

Previous … 36 37 38 39 40 … Next